Could the Audiometric Criteria for Sudden Sensorineural Hearing Loss Miss Vestibular Schwannomas?


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
03 2023
Historique:
revised: 21 04 2022
received: 21 02 2022
accepted: 12 05 2022
pubmed: 29 5 2022
medline: 25 2 2023
entrez: 28 5 2022
Statut: ppublish

Résumé

To investigate the likelihood of missing a vestibular schwannoma (VS) diagnosis in patients who present with a sudden hearing loss (SHL) that does not meet the most accepted audiometric criteria for sudden sensorineural hearing loss (SSNHL) (a decrease of ≥30 dB at three consecutive frequencies). All adult patients (>18 years) diagnosed with SHL of any severity in a tertiary care referral medical center between 2015 and 2020 and who underwent an MRI scan to rule out VS were included. Statistical analyses were conducted to evaluate the difference between the rate of VS among patients with an initial audiogram, which met the abovementioned criteria, and those who did not. Other audiometric criteria for SNHL were also evaluated (≥10 dB at ≥2 frequencies and ≥ 15 dB at one frequency). Of the 332 patients included in the study, 152 met the audiometric criteria for SSNHL, and 180 did not. Both groups had a similar VS rate (8.6% vs. 8.9%, p = 0.914). Similar results were found when other audiometric criteria for asymmetric SNHL were analyzed. In a subgroup analysis of patients with VS-associated SSNHL, neither the tumor size nor the Koos classification was associated with any of the audiometric criteria systems. There should be a high index of suspicion for the presence of VS in patients with an SHL of any severity. 3 Laryngoscope, 133:670-675, 2023.

Identifiants

pubmed: 35633191
doi: 10.1002/lary.30230
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

670-675

Informations de copyright

© 2022 The American Laryngological, Rhinological and Otological Society, Inc.

Références

Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(S1):195-210.
National Institute on Deafness and Other Communication Disorders. NIDCD Fact Sheet: Sudden Deafness. Washington, DC: US Department of Health and Human Services; 2018.
Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol. 2013;34(9):1586-1589.
Sauvaget E, Kici S, Kania R, Herman P, Tran Ba Huy P. Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma. Acta Otolaryngol. 2005;125(6):592-595.
Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope. 2010;120(5):1011-1021.
Ramaswamy AT, Golub JS. Management of vestibular schwannomas for the radiologist. Neuroimaging Clin N Am. 2019;29(1):173-182.
Koos WT, Day JD, Matula C, Levy DI. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg. 1998;88(3):506-512.
Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol. 2003;24(5):728-733.
Sweeney AD, Carlson ML, Shepard NT, et al. Congress of neurological surgeons systematic review and evidence-based guidelines on otologic and audiologic screening for patients with vestibular schwannomas. Neurosurgery. 2018;82(2):E29-E31.
Rauch SD. Idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008;359(8):833-840.
Bhargava EK, Coyle P, Wong B, Masood A, Qayyum A. To scan or not to scan-a cross-sectional analysis of the clinical efficacy and cost-effectiveness of audiometric protocols for magnetic resonance imaging screening of vestibular schwannomas. Otol Neurotol. 2019;40(5S):S59-S66.
Conley M, Diaz RC. Asymmetric sensorineural hearing loss and vestibular schwannoma: when to image? Curr Opin Otolaryngol Head Neck Surg. 2020;28(5):335-339.
Fitzgerald DC, Mark AS. Sudden hearing loss: frequency of abnormal findings on contrast-enhanced MR studies. AJNR Am J Neuroradiol. 1998;19(8):1433-1436.
Lee JD, Lee BD, Hwang SC. Vestibular schwannoma in patients with sudden sensorineural hearing loss. Skull Base. 2011;21(02):75-78.
Cadoni G, Cianfoni A, Agostino S, et al. Magnetic resonance imaging findings in sudden sensorineural hearing loss. J Otolaryngol. 2006 Oct;35(5):310-316.
Saliba I, Martineau G, Chagnon M. Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma. Otol Neurotol. 2009;30(4):515-521.
Saliba I, Bergeron M, Martineau G, Chagnon M. Rule 3,000: a more reliable precursor to perceive vestibular schwannoma on MRI in screened asymmetric sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2011;268(2):207-212.
Shilo S, Ziv-Baran T, Oron Y, et al. Calculated versus measured pure tone bone conduction 3 kHz thresholds in sudden sensorineural hearing loss. J Laryngol Otol. 2021;135(9):820-824.
Fujita T, Saito K, Kashiwagi N, Sato M, Seo T, Doi K. The prevalence of vestibular schwannoma among patients treated as sudden sensorineural hearing loss. Auris Nasus Larynx. 2019;46(1):78-82.
Wasano K, Oishi N, Noguchi M, et al. Sudden sensorineural hearing loss in patients with vestibular schwannoma. Sci Rep. 2021;11(1):1-9.
Arriaga MA, Major MC, Long S, et al. Clinical correlates of acoustic neuroma volume. Am J Otol. 1993;14(5):465-468.

Auteurs

Shahaf Shilo (S)

Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ouriel Hannaux (O)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dor Gilboa (D)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Omer Jacob Ungar (OJ)

Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ophir Handzel (O)

Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Rani Abu Eta (R)

Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Nidal Muhanna (N)

Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yahav Oron (Y)

Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH